The adenoma–carcinoma sequence, first proposed by Vogelstein, outlines the stepwise progression of CRC, with genetic alterations in key oncogenes and tumor suppressors such as APC [6], KRAS [7], and TP53 [8], playing pivotal roles in tumor initiation and progression. The gene discussed is KRAS; the disease is adenoma.